4 insiders reported 5 Form 4 transactions for Hepion Pharmaceuticals, Inc. (HEPA) over the past 18 months (most recent 2026-04-27). Recent activity: Stetz Gary S. (Interim CEO) Buy 1.2M shares, LoPriore Vincent S (Executive Chairman) Buy 5.0M shares, Purcell Michael J. (Director) Buy 1.2M shares, Appajosyula Sireesh (Director) Buy 1.2M shares, LoPriore Vincent S (Executive Chairman) Buy 1.2M shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-27 | Stetz Gary S. | Interim CEO | Buy | 1.2M | $50,000 |
| 2026-04-27 | LoPriore Vincent S | Executive Chairman | Buy | 5.0M | $200,000 |
| 2026-04-27 | Purcell Michael J. | Director | Buy | 1.2M | $50,000 |
| 2026-04-27 | Appajosyula Sireesh | Director | Buy | 1.2M | $50,000 |
| 2026-04-27 | LoPriore Vincent S | Executive Chairman | Buy | 1.2M | $50,000 |
Source: SEC Form 4 filings · as of 2026-04-27
